SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046867
Filing Date
2024-11-19
Accepted
2024-11-19 17:18:45
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1795444
2 ex31-1.htm EX-31.1 20430
3 ex31-2.htm EX-31.2 20437
4 ex32-1.htm EX-32.1 6751
5 ex32-2.htm EX-32.2 6869
  Complete submission text file 0001493152-24-046867.txt   8900414

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE otlc-20240930.xsd EX-101.SCH 63111
7 XBRL CALCULATION FILE otlc-20240930_cal.xml EX-101.CAL 48126
8 XBRL DEFINITION FILE otlc-20240930_def.xml EX-101.DEF 318762
9 XBRL LABEL FILE otlc-20240930_lab.xml EX-101.LAB 443746
10 XBRL PRESENTATION FILE otlc-20240930_pre.xml EX-101.PRE 385703
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1592782
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 241477322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)